Camelyon16 |
H&E stained slides of breast cancer sentinel lymph nodes from 2 centers |
Patient-level labels: pN stage. Pixel-level: partial tumor annotations |
399 WSIs |
WSIs scanned at 20x and 40x magnifications |
Segmentation, slide-level classification, MIL |
Camelyon17 |
H&E stained slides of breast cancer sentinel lymph nodes from 5 centers |
Patient-level pN stage label Pixel-level: partial tumor annotations |
1000 WSIs |
WSIs scanned at 20x and 40x |
Segmentation, classification, MIL |
Patch Camelyon |
Patches extracted from Camelyon16 dataset |
Patch-level label: tumor positive or negative |
327,680 patches |
96x 95 pixel patches at 10x |
Patch classification |
SLN-Breast, TCIA |
H&E stained slides scanned in one center |
Patient-level labels: pN stage label |
130 slides from 78 patients |
WSIs scanned at 20x |
Slide-level classification, MIL |
Axillary lymph nodes in breast cancer, AIDA |
H&E slides of breast cancer sentinel lymph nodes (2 consecutive slices) from multiple scanners |
Patient-level labels: treatment, pN stage, primary tumor. IHC slides for cytokeratin AE1/AE3 |
396 patients |
WSIs scanned at 20x |
Tumor segmentation, slide-level classification, MIL |
Breast cancer lymph nodes for HEV detection |
Immunofluorescently stained HEVs using HEV markers for peripheral node addressin PNAd and vascular marker Claudin-5 |
Immunofluorescence signal for HEVs |
73 patients with invasive, non-invasive breast carcinoma, or cancer-free |
Not specified |
HEV segmentation and diameter evaluation in LNs |
Multi-magnification organ network (MMO-Net) dataset |
H&E stained slides of rat mandibular lymph nodes from 3 centers |
Manual LN contour annotations |
53 WSIs containing lymph nodes, 267 WSIs from other organs |
Not specified |
LN contour segmentation |